Sign In
Buy MEDP
$450.82
+5.23 (+1.17%)
At Close: Jun 03, 2026
Medpace Holdings Inc (NASDAQ:MEDP) VP Susan E. Burwig Sells 6,000 Shares
08:22pm, Sunday, 09'th Aug 2020
Medpace Holdings Inc (NASDAQ:MEDP) VP Susan E. Burwig sold 6,000 shares of Medpace stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $121.14, for a
The Zacks Analyst Blog Highlights: Houghton Mifflin Harcourt Company, CoreLogic, FTI Consulting, Artisan Partners Asset Management and Medpace Holdings
The Global Clinical Trial Management System (CTMS) Market will grow by USD 504.00 mn during 2020-2024
3 Reasons Why Medpace (MEDP) Is a Great Growth Stock
04:45pm, Friday, 31'st Jul 2020
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
Medpace Holdings, Inc. Just Beat EPS By 58%: Here's What Analysts Think Will Happen Next
02:28pm, Thursday, 30'th Jul 2020
As you might know, Medpace Holdings, Inc. (NASDAQ:MEDP) just kicked off its latest second-quarter results with some...
Medpace Holdings, Inc. (NASDAQ:MEDP) Not Flying Under The Radar
11:34am, Wednesday, 29'th Jul 2020
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
12:00am, Wednesday, 29'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 28)
Axonics Modulation Technologies Inc (NASDAQ: AXNX)
Capricor Therapeutics Inc (NASDAQ: CAPR)
Fulgent Genetics Inc...
Medpace Holdings, Inc. Common Stock (MEDP) Q2 2020 Earnings Call Transcript
10:31pm, Tuesday, 28'th Jul 2020
Good morning, and thank you for joining Medpace's second-quarter 2020 earnings conference call. Also on the call today is our president and CEO, August Troendle; and our CFO and COO of laboratory ope
Medpace Stock Soars To Record High On Improving Outlook
08:18pm, Tuesday, 28'th Jul 2020
Medpace Holdings stock soared Tuesday to a record high after the provider of clinical testing and research services for drugmakers late Monday forecast better-than-expected revenue for 2020.
Medspace Holdings (MEDP) Investor Presentation - Slideshow
05:50pm, Tuesday, 28'th Jul 2020
The following slide deck was published by Medpace Holdings, Inc. in conjunction with this event..
Medpace Holdings, Inc. 2020 Q2 - Results - Earnings Call Presentation
05:44pm, Tuesday, 28'th Jul 2020
The following slide deck was published by Medpace Holdings, Inc. in conjunction with their 2020 Q2 earnings call..
Why Medpace Holdings Is Skyrocketing 13.5% Higher Today
04:26pm, Tuesday, 28'th Jul 2020
After reporting second-quarter financials that beat industry watchers' estimates, Medpace Holdings (NASDAQ: MEDP) shares are soaring 13.5% higher at 11:55 a.m. EDT on Tuesday. Investors were concerne
Medpace Holdings, Inc. (MEDP) CEO August Troendle on Q2 2020 Results - Earnings Call Transcript
01:08pm, Tuesday, 28'th Jul 2020
Medpace Holdings, Inc. (NASDAQ:MEDP) Q2 2020 Earnings Conference Call July 28, 2020, 09:00 ET Company Participants Kevin Brady - Executive Director, Finance August Troendle - Chairman, President &
Medpace (MEDP) Q2 Earnings and Revenues Top Estimates (Revised)
08:34am, Tuesday, 28'th Jul 2020
Medpace (MEDP) delivered earnings and revenue surprises of 61.90% and 13.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
